Résultats de la recherche - 2 results
Utilization of gabapentin by people in treatment for substance use disorders in Belgium (2011-2014): a cross-sectional study.
bought gabapentin in a time span that could indicate consumption at a dose that exceeded the maximum approved dose of 3600 mg/day. Methods: This analysis is the result of an observational cross-sectional ...
Treatment for substance use disorders: the Belgian Treatment Demand Indicator registration protocol.
participating in this data collection since then. METHODS / DESIGN: This surveillance register collects information on every treatment episode started by patients for their substance use disorder. Information is ...